The water channel aquaporin-1 (AQP1) mediates about 50% ultrafiltration during a 2-hour hypertonic dwell in global AQP1 knockout (AQP1 -/-) mice. Although AQP1 is widely expressed in various cell types including mesothelial cells, the ultrafiltration has been assumed to be mediated via endothelial AQP1 of the peritoneum. The partial embryonic lethality and reduced body weight in AQP1 -/-mice may reflect potential confounding phenotypic effects evoked by ubiquitous AQP1 deletion, which may interfere with functional analysis of endothelial AQP1. Using a Cre/loxP approach, we generated and characterised endothelial cell-and time-specific AQP1 knockout (AQP1 fl/fl ; Cdh5-Cre + ) mice. Compared to controls, AQP1 fl/fl ; Cdh5-Cre + mice showed no difference in an initial clinical and biological analysis at baseline, including body weight and survival. During a 1-hour 3.86% miniperitoneal equilibration test (mini-PET), AQP1 fl/fl ; Cdh5-Cre + mice exhibited strongly decreased indices for AQP1-related transcellular water transport (43.0% in net ultrafiltration, 93.0% in sodium sieving and 57.9% in free water transport) compared to controls. The transport rates for small solutes of urea and glucose were not significantly altered. Our data provide the first direct experimental evidence for the functional relevance of endothelial AQP1 to the fluid transport in peritoneal dialysis and thereby further validate essential predictions of the three-pore model of peritoneal transport.
Introduction
Despite technical advances, peritoneal dialysis (PD) is still limited by peritoneal membrane (PM) changes resulting in ultrafiltration failure (UFF) [1] . According to the three-pore model of peritoneal transport, dysfunction of the water channel aquaporin 1 (AQP1) in peritoneal endothelial cells is a major cause of UFF [2] . It has been validated in global AQP1 knockout mice (AQP1 -/-) that AQP1 mediated about 50% of ultrafiltration during a 2-hour hypertonic dwell [3] .
AQP1 is the most abundant isoform in the highly vascularised peritoneal membrane (PM), and also the only one that has been consistently located in the capillary endothelium in various species including mouse [3, [4] [5] [6] [7] [8] [9] . Hence, it has been assumed that the UF modification observed in AQP1 -/-mice is predominantly linked to AQP1 located in the endothelium of PM.
To date, however, no experimental data have specifically pinpointed the role of endothelial AQP1 in the UF during PD. Of note, AQP1 is broadly expressed in a variety of cell types and organs, including kidney, lung, mesothelial cells and red blood cells [10] [11] [12] [13] [14] . In particular, expression and function of peritoneal mesothelial AQP1 was regulated by buffer-dependent PD fluids [12] . Moreover, the global gene deficiency from early stages of development on may induce potential complex pleiotropic phenotypes and phenotypic consequences caused by compensatory mechanisms [15] . Indeed, the described AQP1 -/-mice exhibit systemic abnormalities, such as growth retardation with 10 to 15% reduced body weight and partial embryonic lethality with impaired survival in utero and/or in the early neonatal period [16, 17] . The reduced body weight in knockout mice was assumed to interfere with interpreting experimental outcomes, e.g. in studies of hypertension, drug and hormone metabolism, organ development, cell proliferation and apoptosis [18] . Body weight is also known to be an important parameter influencing peritoneal UF calculation [3] . In order to circumvent these limitations for the functional analysis of endothelial AQP1, we generated and characterised a novel endothelial cell (EC)-specific and time-specific inducible AQP1 knockout mouse model (AQP1 fl/fl ; Cdh5-Cre + ) using a Cre/loxP system. According to the three-pore model, during a hypertonic dwell both the transcellular transport of free water without solutes (FTW) across ultrasmall pores (AQP1) and the transport across small pores (UFSP) account for the total net UF (NUF) [2, [19] [20] [21] [22] . In this study, we used the 1-hour mini-peritoneal equilibration test with 3.86% glucose (3.86% mini-PET) [23] , which has been validated as being a simple, fast and more practical method for assessing peritoneal transport characteristics [23] [24] [25] , to investigate the role of the endothelial AQP1 in fluid and solute transport across the PM.
Results
Cre-loxP technology combined with inducible systems was used for generating a tamoxifen inducible endothelial cell-specific AQP1 knockout mouse model, which allowed for inactivating AQP1 expression in an inducible manner at any stage of mouse development.
Generation and Characterisation of Floxed AQP1 Mice
To obtain a floxed AQP1 allele appropriate for Cre-mediated conditional inactivation of the AQP1 gene, a targeting vector was designed and constructed that could insert two loxP sites through homologous recombination flanking exons 2 and 3 of the AQP1 gene in mouse embryonic stem cells (ES cells) (Fig 1) . These exons encode the crucial functional domains, the transmembrane domain (TMD) 4 and 5, as well as NPA motif (asparagine-proline-alanine) of loop E, which has been demonstrated to be implicated in the aqueous pathway [26] .
The correct genomic targeting of the AQP1 floxed construct was obtained and characterised as shown in two representative clones by long-range PCR (Fig 2A) and Southern blot (Fig 2B) , AQP1 fl and AQP1-del allele, the latter of which was obtained by Cre-mediated deletion of exons 2 and 3. With this pair of primers, no PCR product was amplified from the wild type (WT) allele (+) because of the lack of sequences of primer 3R. Primers 4F and 4R were used to differentiate heterozygous floxed AQP1 mice (AQP1 fl/+ ) from homozygous floxed AQP1 mice (AQP1 fl/fl ) (Fig 1 and   Fig 2D) . Intercrosses of heterozygous AQP1 fl/+ mice yielded 129 pups-33 wild-type (25.6%), 65 heterozygous (50.4%), and 31 homozygous (24.0%), which is according to the expected Mendelian ratio. Western blot ( Fig 2E) and immunohistochemistry (IHC) analysis (Fig 2F) showed that the expression level and cellular distribution of the AQP1 gene in visceral peritoneum (VP) of AQP1 fl/fl mice were indistinguishable from those of AQP1 +/+ mice. Survival, Mendelian inheritance of the AQP1 fl allele and unaltered expression of AQP1 proteins are all indications of normal gene expression from the AQP1 allele with loxP-flanked exons 2 and 3. EC-specific Cre-mediated deletion efficiency was investigated by immunocytochemistry (ICC) staining of ECs isolated from lung or VP (Fig 3) , and immunohistochemistry (IHC) staining of VP sections (Fig 4A and 4B) . CD31-stained cells in both groups showed similar immunoactivity. In the absence of Cre recombinase, AQP1 was strongly expressed in the cultured ECs, but it was remarkably diminished in ECs with Cre recombinase expression. Quantification of the relative CD31-stained endothelial area in the VP sections showed no significant difference between the AQP1 fl/fl ; Cdh5-Cre -mice and AQP1 fl/fl ; Cdh5-Cre + mice (Fig 4B, left) .
This confirms that the endothelial area was not significantly altered by the deletion of AQP1 Equal loading (10 μg of protein from each sample) was verified using an anti-β-actin antibody. Scanning densitometric analysis of AQP1 protein expression (AQP1 protein/β-actin) was done using Image J (right). Data are expressed as a ratio relative to the control group. Each bar indicates mean ± S.E. ÃÃÃ P < 0.001.
Comparison of the signal intensity obtained from lung and EC DNA samples extracted from the AQP1 fl/fl ; Cdh5-Cre -and AQP1 fl/fl ; Cdh5-Cre + mice indicates a high degree of specific excision of exon 2 and 3 in the ECs (Fig 4C) . Western blot analysis also demonstrated the efficiency of AQP1 deletion in lung ECs ( Fig  4D) . Compared to AQP1 fl/fl Cdh5-Cre -mice (n = 4), the level of AQP1 protein was diminished in AQP1 fl/fl Cdh5-Cre + mice (n = 11) by 89.0%.
Clinical and Biological Parameters of the Endothelial Cell-specific AQP1 Knockout Mice
In comparison with control (AQP1fl/fl; Cdh5-Cre-) mice, AQP1fl/fl; Cdh5-Cre+ mice with the specific deletion of AQP1 in ECs showed no difference in an initial clinical and biological analysis at baseline including body weight ( Table 1) .
Role of AQP1 in UF and Small Solute Transport During Mini-PET 
Discussion
Ultrafiltration (UF) is an important cause for peritoneal dialysis (PD) failure [1] . The threepore model of peritoneal transport predicts that the water channel AQP1 is the ultrasmall pore located in the endothelial cells and mediates about 50% of ultrafiltration during a 2h-dwell. This concept has been validated experimentally in global AQP1 knockout mice (AQP1 -/-) [6] .
The present study bypassed the drawbacks of potential confounding phenotypic effects from ubiquitous deletion of AQP1 gene, using a well-characterised inducible endothelial cell-specific AQP1 knockout mouse model, to investigate the central functions of endothelial AQP1 in UF during PD. To achieve cell-specific and /or conditional gene knockout, first we generated the AQP1 fl/fl mice. It showed that the insertions of loxP sites do not interfere with expression of the floxed gene and normal protein production (Fig 2E and 2F) . Then, the floxed AQP1 alleles were converted to the deleted AQP1 alleles in a tamoxifen inducible manner by endothelial-specific Cre-mediated excision of exons 2 and 3. The resulting AQP1 fl/fl ; Cdh5-Cre + mice revealed a high efficient EC-specific deletion of the AQP1 in tissues (Figs 3 and 4) with strongly expressed AQP1 such as lung and PM [3, 16] . In contrast to global AQP1 knockout mice with impaired survival, lower body weight [16, 17] (Table 1) . Body weight is known to be an important parameter for interpreting experimental outcomes including peritoneal UF calculation [3, 18] . Therefore, the endothelial cell-and time-specific AQP1 knockout (AQP1 fl/fl ; Cdh5-Cre + ) mice will provide a more specific experimental model for functional investigation of endothelial AQP1. To our best knowledge, this is the first report on an inducible endothelial cell-specific AQP1 knockout mouse model. Although the 1-hour 3.86% mini-PET has been validated to be a simple, fast and more practical method for assessing AQP1-related solute-free water transport [23] , no specific data have been provided in a mouse PD model yet. In addition, until now no data have showed the association between endothelial AQP1 function and its related clinical relevance for UF in PD. The present study addressed the question, using 1h 3.86% mini-PET in the well-characterised tamoxifen-inducible endothelial cell-specific AQP1 knockout mouse model.
During a 1-hour 3.86% mini-PET, AQP1 fl/fl ; Cdh5-Cre + mice exhibited strongly decreased indices for AQP1-related transcellular water transport (43.0% in net UF, 93.0% in sodium sieving and 57.9% in free water transport) compared to control AQP1 fl/fl ; Cdh5-Cre -mice (Table 2 and Fig 5) . The transport rates for urea and glucose were not significantly altered (Table 2) . These data confirm the hypothesis that deletion of endothelial AQP1 significantly decreases water transport during the 3.86% mini-PET, without significant changes in small solute transport parameters. It has also been suggested that the deletion of exons 2 and 3 in AQP1 gene may putatively destroy the symmetrical membrane-spanning "hour-glass" structure of mouse AQP1 protein, which has a great functional impact on the resulting AQP1 channel protein [26] . [25] . Compared to normal UF patients, UF failure patients showed a 42% decrease in Net UF and a 56% decrease in FWT at the end of the 3.86% mini-PET. Our data provide the first direct evidence for the crucial role of AQP1 expressed in endothelium during 3.86% mini-PET and thereby validate not only essential predictions of the threepore model, but also the essential role of endothelial AQP1 in ultrafiltration and free water transport during peritoneal dialysis.
Modulation of endothelial AQP1 might provide a promising therapeutic target for preventing ultrafiltration failure in peritoneal dialysis. These findings may also contribute to an improved understanding of AQP1-endothelial biology, such as angiogenesis, wound healing, tumour spread and organ regeneration.
Material and Methods

Generation of Inducible Endothelial Cell-specific AQP1 Knockout Mice
The Cre/loxP system was employed to generate the conditional knockout mice. A targeting vector that encompasses 17.2 kb of the AQP1 locus and a loxP / FRT site-flanked pro-and eukaryotic neomycin selection cassette (Neo-gb2-PGK) was designed (Gene Bridges GmbH, INF 584, Heidelberg, Germany) (Fig 1A) . The PGK-gb2-neo template encodes the neomycin/ kanamycin resistance gene which combines a prokaryotic promoter (gb2) for expression of kanamycin resistance in E.coli with a eukaryotic promoter (PGK) for expression of neomycin resistance in mammalian cells. Embryonic stem cells (ES cells, 129/Ola) were transfected with the linearised targeting construct, and subjected to G418 selection (300 μg / ml). The surviving clones were screened for homologous recombination by long-range PCR with LATaq DNA polymerase (TaKaRa, Otsu, Japan) and the PCR primers are listed in Table 3 . The PCR-positive clones were then confirmed by Southern blot by using 339bp and 415bp fragments of the intron sequence as a 5' or 3' probe, respectively. These two fragments were created by PCR from wild type 129/Ola genomic DNA by primers probe 5F/5R and probe 3F/ 3R (Table 3 ) and then labelled with alkaline phosphatase using AlkPhos Direct Labelling and Detection system with CDP-star (Amersham). 15 μg of genomic DNAs were digested with Nsi I or Xho I, electrophoresed, transferred to a nylon membrane, hybridised with the labelled probes. Southern blot analysis was also preformed with a neo probe to exclude additional random integrations of the targeting vector DNA.
The correctly targeted ES clones were expanded and injected into C57BL/6 blastocysts (Biotech Lab., Interfacultary Biomedical Faculty, University Heidelberg, Germany) to yield chimeric founder mice. 
Mouse Genotype Analysis by PCR
The locations of all PCR primers used for genotyping are indicated in Fig 1. All PCR primer sequences and their related amplification sizes are listed in Table 3 . Mouse genomic DNA samples were prepared from tail tips by following standard protocols.
Peritoneal Transport Studies
All animal procedures were approved by the University of Heidelberg Animal Care Committee and were performed on mice according to the guidelines of the Institute of Laboratory Animal Science of the University of Heidelberg. Two weeks after last IP injection of tamoxifen, 8-week-old mice were submitted to a 1h mini-PET with 3.86% glucose-based dialysate (2.0 ml; Baxter Deutschlang GmbH, Munich, Germany) without anaesthesia. Each group contained 6 or 12 mice (n = 6, 4 male and 2 female; n = 12, 8 male and 4 female).
To minimise animal suffering and distress: (i) mice were treated with the shorter dwell time (1 hour) compared to the published data [3] ; (ii) at the end of the dwell, mice were anaesthetised with Ketamine (100 mg/kg i.m, Bremer Pharma GMBH, Warburg, Germany) and Xylazine (5 mg/kg i.m, Ecuphar GMBH, Germany), (iii) at the end of the peritoneal transport study (the dialysate samples were recovered from the peritoneal cavity [7] and blood samples were taken from the posterior vena cava), mice were enthanised by cervical dislocation. Peritoneum and lung samples were processed for further investigation, such as immunohistochemistry (IHC) analysis, immunocytochemistry (ICC) analysis and isolation of endothelial cells.
During the 1-hour dwell, mice were monitored every 15 minutes and were enthanised by cervical dislocation if they were in a state of respiratory distress. There were no unexpected deaths and all mice survived during the 1-hour dwell. All parameters from the plasma and dialysate were assessed using Roche/Hitachi cobas c311 in the Medical Research Centre, University Medical Centre Mannheim, Mannheim, Germany. Sodium plasma and dialysate levels were measured with ISE indirect Na, K, CI for Gen.2, glucose levels with Glucose HK in haemolysate Gen.2, and urea with Urea/BUN, respectively. Dialysate creatinine levels were measured with the Jaffe method in the central laboratory of Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
The following calculations were performed [7, 23 ]:
1. Total net UF (NUF) NUF (μl) = (VD60-VD0), where VD0 and VD60 are the volume (μl) of the recovered dialysate at 0 and 60 minutes of the dwell time. V0 was equal to 1.985 ml [an average volume recovered from 6 8-week-old mice (4 males and 2 females), immediately after 2 ml IP injection with 3.86% glucose-based dialysate]
2. Dialysate / plasma sodium concentration (mmol/L) ratio at 0 minute (Na0D/P) and at 60 minutes of the test (Na60D/P). Plasma sodium concentration at the start (Na0P) was an average concentration obtained from 6 mice of each group without processing the 3.86% mini-PET.
Sodium sieving (%) during the mini-PET
Sodium sieving ð%Þ ¼ ðNa0D=P À Na60D=PÞ = Na0D=P 100 ðin %Þ 4. UF through small pores (UFSP):
, where UFSP is UF through small pores, Nap is plasma Na concentration and NaR is sodium removal. NaR = (Na60D X VD60) − (Na0D X VD0), where Na60D and VD60 are Na concentration (mmol/L) and volume in the effluent (μl) at 60 minutes of the test. Na0D and VD0 are the Na concentration (mmol/L) and volume (μl) of infused at 0 h of dwell time.
Free water transport (FWT):
FWT ðmlÞ ¼ NUF ðmlÞ À UFSP ðmlÞ According to the established three-pore model of PD, UF occurs either through capillary small pores and accompanied by a solute (e.g. sodium, urea), or transcellular fluid transport that is selective for water only and occurs through specialised AQP1 water channels [22] . Therefore, free water transport (FWT) can be calculated with the La Milia method [23] by using sodium concentration values in dialysate and plasma, as well as NUF.
It has been known that, during the first hour of a hypertonic dwell, free water transport is maximal (since the glucose dialysate concentration is at its peak) and that the diffusive transport of sodium from blood to dialysate is very low (sodium concentration is close to its equilibrium across the peritoneal membrane and thus its gradient for diffusion is very low) [23] . In these conditions, nearly all the sodium transport is due to convection through small pores and thus the ratio of sodium removal (NaR) to plasma water sodium concentration gives the value of UF through the small pores (UFSP). It is then easily possible to calculate FWT by subtracting UFSP from total NUF.
Because the 3.86% mini-PET of La Milia et al. only provides more accurate information on free water transport when a correction for sodium diffusion is made [24] , a correction for all dialysate sodium (NaD) is made with the mass transfer area coefficient of creatinine as described by Westra et al. [28] .
NUF, FWT and sodium sieving were used as indexes for transcellular water transport by AQP channels, and glucose D60/D0 and urea D60/D0 ratio were measured to evaluate the peritoneal transport for small solutes [23] .
Immunohistochemistry
The visceral peritoneum (VP) was removed and fixed in 4% paraformaldehyde or zinc for 24 h, and then embedded in paraffin, sectioned (4 μm). Following standard steps [deparaffinising and rehydrating the slides and antigen retrieval (citrate buffer method, pH 6)], paraformaldehyde-fixed VP slides were incubated with 1:100 rabbit anti-AQP1 (Biozol Diagnostica GmbH, Eching, Germany) for 1 h, Histofine Simple stain AP (Multi) Anti rabbit (Nichirei Bioscience Inc, Tokyo, Japan) for 30min, Alkaline Phosphatase-conjugated streptavidin (AP-Label) (Biogenex, Fremont, CA, USA) for 20 min, Hemalum (Carl Roth, Karlsruhe, Germany) for 1 min, and finally detected with Fast-Red.
Zinc-fixed VP slides were washed three times in dH 2 O and blocked (7% BSA, 10% goat serum, 0.2% Triton X-100 in PBS) for 30 min, and then incubated with 1:100 rabbit anti-AQP1 (Biozol Diagnostica GmbH, Eching, Germany) and 1:100 Hamster anti-CD31 (Millipore, Merck Chemicals GmbH, Darmstadt, Germany) overnight at 4°C. Following those steps, the slides were washed three times with 0.2% Triton X-100 in PBS and incubated with secondary antibody ; Cdh5-Cre + mice. Processed images were imported to ImageJ where the intensity threshold was set automatically and analysed for units of positive pixel area. The relative endothelial area (the ratio between the CD31-stained area and the entire VP area, in %), or the relative endothelial AQP1 area (the ratio between the AQP1-stained area and the CD31-stained area, in %) was measured. All slides were masked to prevent bias and imaged at 20× magnification. No less than three fields of view (FOV) were obtained per slide, no less than 10-15 FOV were obtained per animal and five animals were evaluated.
Primary Culture of Endothelial Cells
ECs isolated from lung [29] or VP [30] were cultured from 8-week-old mice by a modified method. Briefly, the lung or VP were minced and digested in collagenase A solution (1 mg/ml, Roche Diagnostics GmbH, Mannheim, Germany) at 37°C for~60 minutes. The cellular digest was filtered through sterile 40 μm nylon mesh and centrifuged at 800 g for 10 minutes. The cell suspension in 10% FCS-DMEM (Dulbecco's modified Eagle's medium containing 10% foetal calf serum) was incubated with Dynabeads (M-450, sheep-anti-rat IgG, Dynal, Life Technologies, CA, USA) for 30 minutes at 4°C. The bead-bound cells were recovered, washed with 10% FCS-DMEM and FCS-free DMEM, and then digested for 5 to 10 minutes at 37°C with trypsin/ EDTA (GIBCO, Life Technologies, CA, USA) to release the beads. The bead-free cells were centrifuged in 10% FCS-DMEM and then resuspended in EC culture medium.
Immunocytochemistry
ECs cultured on glass coverslips were rinsed with phosphate-buffered saline (PBS) and fixed in 3% paraformaldehyde (PFA) for 5 min. Then cells were incubated with 0.1% Triton X-100 for 1 min. After being washed with PBS, the cells were incubated with primary antibodies (1:50 rabbit anti-AQP1, Biozol Diagnostica GmbH, Eching, Germany; 1:50 Hamster anti-mouse CD31, Millipore Merck Chemicals GmbH, Darmstadt, Germany) in blocking solution (2% FCS, 0.2% fish gelatine, 2% BSA in PBS) for 2 hours at room temperature. The cells were then washed with PBS (three times, 5 min each), and incubated for 45 min at room temperature with secondary antibodies (1:200 Cy3-conjugated donkey anti-rabbit IgG, Dianova, Hamburg, Germany; 1:200 goat anti-Hamster AlexaFlour 488, Dianova, Hamburg, Germany) and 1:1000 Hoechst 33342. Next, the cells were washed three times with PBS, for 5 min each time. Finally, the cells were washed twice in dH 2 O for 3 minutes and mounted for microscopic visualisation.
Image Acquisition
For the immunoassay, images for cells and tissue slides were acquired using the Nikon Eclipse 80i upright automated microscope with a Nikon Plan Fluor 20x NA 0.50 objective (Nikon GmbH, Düsseldorf, Germany). Image acquisition and processing were controlled by NIS Elements BR 3.0 software. The images were visualised and processed with Image J.
Western Blot
Tissue or EC samples were homogenised in lysis buffer. Approximately 40μg of tissue protein from VP or 10μg EC protein from lung was separated by 12% SDS-PAGE, transferred to a PVDF Membrane (WesternBreeze Chromogenic Western Blot, Invitrogen, Life Technologies, CA, USA), and incubated with 1:500 rabbit anti-AQP1 (Biozol, Hamburg, Germany) overnight (4°C). Samples were treated with alkaline phosphatase-conjugated anti-rabbit secondary antibody, and immunoreactivity was detected by using the WesternBreeze1 Chromogenic Kit according to the manufacturer's specifications (WesternBreeze Chromogenic Western Blot, Invitrogen, Life Technologies, CA, USA). The intensity of the resulting bands was quantified by densitometry using Image J.
Statistical Analyses
The statistical data were presented as the means ± S.E. Statistical significance was evaluated with the Student's t-test for pairwise comparison of data. Differences were considered significant when a p value was < 0.05. In the figures, significance levels are shown as asterisks (" Ã " for p < 0.05, " ÃÃ " for p < 0.01, " ÃÃÃ " for p < 0.001).
